Researcher
Catherine Verfaillie
- Disciplines:Genetics, Systems biology, Molecular and cell biology
Affiliations
- Stem Cell and Developmental Biology (Division)
Member
From1 Apr 2013 → 30 Sep 2022
Infrastructure
1 - 1 of 1
- Platform for Next Generation Screening in Quantitative Biology & Drug Discovery (Consortium coordinator)
Projects
91 - 95 of 95
- Understanding hematopoiesis defect underlying Fanconi Anemia.From1 Oct 2008 → 14 Oct 2014Funding: IWT personal funding - strategic basic research grants
- Stem cell mediated muscle hypertrophy as a therapeutic strategy for muscular dystrophies.From1 Oct 2008 → 31 Dec 2013Funding: IWT personal funding - strategic basic research grants
- Recovery following Brain Injury - The Role of Stem Cells, Studied in a Rodent Model of Focal Cerebral IschaemiaFrom23 Jun 2008 → 14 Sep 2014Funding: Own budget, for example: patrimony, inscription fees, gifts
- A partial agonist of c-met to induce muscle hypertrophyFrom1 Jan 2008 → 31 Dec 2008Funding: Own budget, for example: patrimony, inscription fees, gifts
- Immunomodulatory actions of multipotent adult progenitor cells and myeloid-derived suppressor cells in T cell alloreactivity assays. Implications for immunomodulating cell therapy.From1 Jan 2008 → 31 Jul 2011Funding: IWT personal funding - strategic basic research grants
Publications
1 - 10 of 375
- Xenografted human microglia display diverse transcriptomic states in response to Alzheimer's disease-related amyloid-β pathology.(2024)
Authors: Sriram Balusu, Catherine Verfaillie, Bart De Strooper
- Glycolytic state of aortic endothelium favors hematopoietic transition during the emergence of definitive hematopoiesis.(2024)
Authors: Catherine Verfaillie
Pages: eadh8478 - Spatially Self-Organized Three-Dimensional Neural Concentroid as a Novel Reductionist Humanized Model to Study Neurovascular Development(2024)
Authors: Yoke Chin Chai, San Kit To, Yingli Zhu, Ben van der Veer, Vincent Pasque, Catherine Verfaillie
- Osmolar Modulation Drives Reversible Cell Cycle Exit and Human Pluripotent Cell Differentiation via NF-κВ and WNT Signaling(2024)
Authors: Jonathan Chui, Aneta Malesa, Paraskevi ATHANASOULI, Joris Vriens, Kian Koh, Catherine Verfaillie, Frederic Lluis Vinas
- Robotics-Driven Manufacturing of Cartilaginous Microtissues for Skeletal Tissue Engineering Applications(2024)
Authors: Isaak Decoene, Gabriele Nasello, Catherine Verfaillie, Liesbet Geris, Frank Luyten, Ioannis Papantoniou
Pages: 278 - 292 - Automated Generation of hiPSC-Derived Hepatic Progeny by Cost-Efficient Compounds(2023)
Authors: Kristof De Vos, Teresa Izuel Idoype, Pieter Annaert, Frederic Lluis Vinas, Catherine Verfaillie
Pages: 1076 - 1088 - Editorial: New insights of immune cells in cardiovascular and metabolic disorders(2023)
Authors: Catherine Verfaillie
- Engineering Neurovascular Organoids and Morphogen Gradients with 3D Printed Microfluidic Chips(2023)
Authors: Idris Salmon, Adrian Ranga, Catherine Verfaillie
- APEX1 Nuclease and Redox Functions are Both Essential for Adult Mouse Hematopoietic Stem and Progenitor Cells(2023)
Authors: Samantha Zaunz, Lukas Lauwereins, Kim De Keersmaecker, Catherine Verfaillie
Pages: 2052 - 2072 - From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions(2023)
Authors: Catherine Verfaillie
Pages: 283 - 299
Patents
1 - 10 of 10
- Methods for differentiating cells into hepatic stellate cells (Inventor)
- Hydrogels for cell culture (Inventor)
- Nek6 inhibition to treat als and ftd (Inventor)
- Spheroidal self-assembled peptide hydrogels comprising cells (Inventor)
- Methods for differentiating cells into hepatic stellate cells (Inventor)
- Cell culture media for differentiation of stem cells into hepatocytes (Inventor)
- Methods for identifying activators and suppressors (Inventor)
- Stem cell aggregates and methods for making and using (Inventor)
- Cell therapy for myelodysplastic syndromes (Inventor)
- Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells (Inventor)